Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes

Cancer Biology and Therapy

Volumn 3, Issue 1, 2004, Pages 110-120

  McDonald, Shannon L ^a   Edington, Howard D ^b   Kirkwood, John M ^a   Becker, Dorothea ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Fluorescence imaging; Melanoma; Microarray analysis

Indexed keywords

CYSTATIN; CYSTATIN 8; FLUOROCHROME; NEUROENDOCRINE SECRETORY PROTEIN 55; OLIGONUCLEOTIDE; PROTEIN; RNA; UNCLASSIFIED DRUG; ENZYME; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DYSKERATOSIS CONGENTIA 1 GENE; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; LYMPH NODE METASTASIS; MELANOMA; NIEMANN PICK DISEASE C2 GENE; OPTICS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SUPPRESSION OF TUMORIGENICITY 13 GENE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; ENZYMES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 3142554540     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.1.662     Document Type: Article

References (39)

1. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000; 406:536-40.
2. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000; 406:532-5.
3. Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry. PNAS 2001; 98:8018-23.
4. Loftus SK, Chen Y, Gooden G, Ryan JF, Birznieks G, Hilliard M, et al. Informatic selection of a neural crest-melanocyte cDNA set for microarray analysis. PNAS 1999; 96:9277-80.
5. Loftus SK, Pavan WJ. The use of expression profiling to study pigment cell biology and dysfunction. Pigment Cell Res 2000; 13:141-6.
6. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002; 109:707-18.
7. Valery C, Grob JJ, Verrando P. Identification by cDNA microarray technology of genes modulated by artificial ultraviolet radiation in normal human melanocytes: Relation to melanocarcinogenesis. J Invest Dermatol 2001; 117:1471-82.
8. Wang E, Miller LD, Ohnmacht GA, Mocellin S, Perez-Diez A, Petersen D, et al. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res 2002; 62:3581-6.
9. Seykora JT, Jih D, Elenitsas R, Horng WH, Elder DE. Gene expression profiling of melanocytic lesions. Am J Dermatopathol 2003; 25:6-11.
10. Rodeck U, Becker D, Herlyn M. Basic fibroblast growth factor in human melanoma. Cancer Cells 1991; 3:308-11.
11. Satyamoorthy K, Herlyn M. Cellular and molecular biology of human melanoma. Cancer Biol Ther 2002; 1:14-7.
12. Becker D, Meier CB, Herlyn M. Proliferation of human malignant melanomas is inhibited by antisense oligonucleotides targeted against basic fibroblast growth factor. EMBO J 1989; 8:3685-91.
13. Dirks RW, van Gijlswijk RPM, Vooijs MA, Smit AB, Bogerd J, Van Minnen J, et al. 3′-end fluorochromized and haptenized oligonucleotides as in situ hybridization probes for multiple, simultaneous RNA detection. Exp Cell Res 1991; 194:310-5.
14. Valesky M, Spang AJ, Fisher GW, Farkas DL, Becker D. Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis. Mol Med 2002; 8:103-12.
15. Pfaff Smith A, Kirkwood JM, Edington HD, Jukic DM, Farkas DL, Becker D. Fluorescence imaging analysis of upstream regulators and downstream targets of STAT3 in melanoma precursor lesions obtained from patients before and after systemic low-dose interferon-α treatment. Mol Imag 2003; 2:65-73.
16. Ramakrishnan R, Dorris D, Lublinsky A, Nguyen A, Domanus M, Prokhorova A, et al. An assessment of Motorola Codelink™ microarray performance for gene expression profiling applications. Nucl Acids Res 2002; 30:1-12.
17. Zhang Y, Cai X, Schlegelberger B, Zheng S. Assignment of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24→q25 by in situ hybridization. Cytogenet Cell Genet 1998; 83:56-7.
18. Zheng S, Cai X, Cao J, Zheng L, Geng L, Zhang Y, et al. Screening and identification of down-regulated genes in colorectal carcinoma by subtractive hybridization: A method to identify putative tumor suppressor genes. Chin Med J 1997; 110:543-7.
19. Lekesjoki AE. Molecular background of progressive myoclonus epilepsy. EMBO J 2003; 22:3473-8.
20. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, et al. X-linked dyskeratosis congenital is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19:32-8.
21. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001; 413:432-5.
22. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, et al. Dyskeratosis Congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003; 299:259-62.
23. Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, Wolkersdorfer M, Winkler H, Fischer-Colbrie R. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 1997; 272:11657-62.
24. Jakobsen AM, Ahlman H, Kolby L, Abrahamsson J, Fischer-Colbrie R, Nilsson O. NESP55, anovel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids. Br J Cancer 2003; 88:1746-54.
25. Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 2000; 290:2298-301.
26. Yang P, Farkas DL, Kirkwood JM, Abernethy JL, Edington HD, Becker D. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma. Mol Med 1999; 5:785-94.
27. Yang P, Becker D. Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma. Int J Oncol 2000; 17:913-9.
28. Parmiter AH, Nowell PC. Cytogenetics of melanocytic tumors. J Invest Dermatol 1993; 100:254S-8S.
29. Sossey-Alaoui K, Kitamura E, Head K, Cowell JK. Characterization of FAM10A4, a member of the ST13 tumor suppressor gene family that maps to the 13q14.3 region associated with B-cell leukemia, multiple myeloma, and prostate cancer. Genomics 2002; 80:5-7.
30. Prapapanich V, Chen S, Nair SC, Rimerman RA, Smith DF. Molecular cloning of human p48, a transient component of progesterone receptor complexes, and an Hsp70-binding protein. Mol Endocrinol 1996; 10:420-31.
31. Fan GH, Yang W, Sai J, Richmond A. Hsc/Hsp70 interacting protein (hip) associates with CXCR2 and regulates the receptor signaling and trafficking. J Biol Chem 2002; 277:6590-7.
32. Barreto A, Gonzalez JM, Kabingu E, Asea A, Fiorentino S. Stress-induced release of HSC70 from human tumors. Cell Immunol 2003; 222:97-104.
33. Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, et al. A high-affinity conformation of Hsp90 confers tumour selectivity of Hsp90 inhibitors. Nature 2003; 425:407-10.
34. Bar-Eli M. Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 1999; 67:12-8.
35. Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 2002; 161:125-34.
36. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995; 269:1585-8.
37. Levicar N, Kos J, Blejec A, Golouh R, Vrhovec I, Frkovic-Grazio S, Lah TT. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Detect Prev 2002; 26:42-9.
38. Kos J, Werle B, Lah T, Brunner N. Cysteine proteinases and their inhibitors in extracellular fluids: Markers for diagnosis and prognosis in cancer. Int J Biol Markers 2000; 15:84-9.
39. Fischer-Colbrie R, Eder S, Lovisetti-Scamihorn P, Becker A, Laslop A. Neuroendocrine secretory protein 55: A novel marker for the constitutive secretory pathway. Ann NY Acad Sci 2002; 971:317-22.